Maternal Serum Screen, Alpha Fetoprotein




Test Mnemonic

AFPMAT

CPT Codes

  • 82105 - QTY (1)

Aliases

  • AFP Neural Tube Defects

Includes

  • Patient's AFP
  • MoM for AFP
  • Maternal Screen Interpretation
  • Maternal Age At Delivery
  • Maternal Weight
  • Estimated Due Date
  • Gestational Age Calculated at Collection
  • Dating
  • Number of Fetuses
  • Maternal Race
  • Insulin Req Maternal Diabetes
  • Smoking
  • Family Hx Neural Tube Defect
  • Specimen

Performing Laboratory

ARUP


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) RefrigeratedSpecimen must be drawn between 14 weeks, 0 days and 24 weeks, 6 days gestation. Separate from cells ASAP or within 2 hours of collection and transfer to standard aliquot tube. See Special Information for list of required patient demographic information.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumNo additive (Red) RefrigeratedSpecimen must be drawn between 14 weeks, 0 days and 24 weeks, 6 days gestation. Separate from cells ASAP or within 2 hours of collection and transfer to standard aliquot tube. See Special Information for list of required patient demographic information.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: 72 hours
RefrigeratedAfter separation from cells: 2 weeks
FrozenAfter separation from cells: 1 year (Avoid repeated freeze/thaw cycles)

Days Performed

Sun - Sat

Turnaround Time

3 - 4 days

Methodology

Name Description
Chemiluminescence Immunoassay (CLIA) 

Reference Range

Special Info

Specimen must be drawn between 14 weeks, 0 days and 24 weeks, 6 days gestation. Submit with Order: Patient's date of birth, current weight, due date, dating method (US, LMP), number of fetuses present, patient's race, if the patient was diabetic at the time of conception, if there is a known family history of neural tube defects, if the patient is currently smoking, if the patient is taking valproic acid or carbamazepine (Tegretol), if this is a repeat sample, and the age of the egg donor if an in vitro fertilization. Hemolyzed specimens will be rejected. This test is New York state approved.

Clinical Info

Second-trimester screening test for open neural tube defects.